MedTrace Logo

Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care

NCT00308724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2024-03-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.

Conditions

  • Generalized Anxiety Disorder

Interventions

BEHAVIORAL

Cognitive Behavior Therapy

8 to 10 in person CBT sessions up to 60 minutes in duration within a 12 week time period

BEHAVIORAL

Telephone check-in

Biweekly telephone calls to monitor symptom severity, an enhanced Usual Care condition

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Kelsey Research Foundation

    collaborator OTHER

  • Kelsey-Seybold Clinic

    collaborator OTHER

  • Michael E. DeBakey VA Medical Center

    collaborator FED

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Melinda A. Stanley, Ph.D. · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2008-01-31
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308724 on ClinicalTrials.gov